Results 201 to 210 of about 10,839 (246)

Facile one-pot four-component synthesis of 3,4-dihydro-2-pyridone derivatives: novel urease inhibitor scaffold.

Res Pharm Sci, 2017
Hakimi AM, Lashgari N, Mahernia S, Ziarani GM, Amanlou M.   +4 more
europepmc   +1 more source

Therapeutic horizons in the development of PROTAC-based EZH2 inhibitors: recent achievements, comparative analysis, and future perspectives. [PDF]

RSC Adv
S Abulkhair H.
europepmc   +1 more source

Kinetics of Singlet Oxygen Release from Endoperoxides of 2-Pyridone Derivatives

, 2011
Lan Luo
openalex   +1 more source

Palladium-Catalyzed Non-Directed C─H Functionalization of Arenes with Trifluoromethylated Olefins. [PDF]

Chemistry
Stockmann L, Empel C.
europepmc   +1 more source

Benchmarking ML in ADMET predictions: the practical impact of feature representations in ligand-based models. [PDF]

J Cheminform
Kamuntavičius G, Paquet T, Bastas O, Šalkauskas D, Prat A, Aty HA, Pabrinkis A, Norvaišas P, Tal R.   +8 more
europepmc   +1 more source

Drug Loading and Release: Development and Characterization of a Novel Therapeutic Agent-Nanographene Conjugate. [PDF]

J Phys Chem B
Hu K, Pavan A, Semeraro A, Ongaro A, Brambilla L, De Rosa MC, Tommasini M, Castiglioni C, Maggini M.   +8 more
europepmc   +1 more source

Synthesis of ring fused 2-pyridones

, 2015
openaire   +1 more source

Polynuclear cobalt complexes of 2-pyridones

, 1994
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Tetrachlorobis(2-pyridone)-bis(μ2-2-pyridone)-dicopper

Acta Crystallographica Section C Crystal Structure Communications, 1993
In this structure two Cu II centres 3.4448 (11) A apart are bridged asymmetrically by two 2-pyridone ligands and each is further coordinated by three terminal ligands (two chlorides and one 2-pyridone). Each molecule has an approximate, non-crystallographic centre of symmetry.
A. J. Blake, R. E. P. Winpenny
openaire   +1 more source